Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple‐Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. - Lei, Josh Haipeng; Lee, Mi‐Hye; Miao, Kai; Huang, Zebin; Yao, Zhicheng; Zhang, Aiping; Xu, Jun; Zhao, Ming; Huang, Zenan; Zhang, Xin; Chen, Si; Jiaying, NG; et al. (Advanced Science, 2023)